Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer

Clinical trial NCT00733850 · COMPLETED

Trial details

NCT number: NCT00733850
Sponsor: KangLaiTe USA
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2008-08-01
Primary completion: 2014-06-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.